Metraipolis › archive › dc_93c2ba24ead5

Impact of CYP2C19*2 on Clopidogrel Response and Cardiovascular Outcomes in ST-segment elevation myocardial infarction Patients — Europe PMC PMID:41737156

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41737156
DOI
10.12669/pjms.42.1.12358
License (as archived)
solo-consultazione
Archived
2026-11-07T06:53:10.003Z
SHA-256 of the archived text
9cb9dd51d1369917110d6e3d836e6ecee9c764af7e4511642e7695764b174c61
Stable URL of this page
https://metraipolis.com/documento/dc_93c2ba24ead5

How to cite

Impact of CYP2C19*2 on Clopidogrel Response and Cardiovascular Outcomes in ST-segment elevation myocardial infarction Patients — Europe PMC PMID:41737156 — Europe PMC (en), https://europepmc.org/article/MED/41737156 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93c2ba24ead5 (Metraipolis archive dc_93c2ba24ead5, sha256 9cb9dd51d1369917110d6e3d836e6ecee9c764af7e4511642e7695764b174c61)
BibTeX
@misc{dc93c2ba24ead5,
  title = {Impact of CYP2C19*2 on Clopidogrel Response and Cardiovascular Outcomes in ST-segment elevation myocardial infarction Patients — Europe PMC PMID:41737156},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41737156},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93c2ba24ead5; sha256 9cb9dd51d1369917110d6e3d836e6ecee9c764af7e4511642e7695764b174c61},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737156. Agents can read the archived copy with the MCP tool read_document.